NLRP3 and type 2 diabetes mellitus: Targeting NLRP3 significantly reduces physical, biochemical, and molecular markers associated with diabetic nephropathy, providing protection from high glucose-induced glomerular injury, changes which initiate progression of kidney injury in both T1DM and T2DM.